The Medicine Forum
Volume 13

Article 5

2012

A 47-Year-Old Female with Shortness of Breath
Dana Marrero, MD
Thomas Jefferson University

Kelly Wright, MD
Thomas Jefferson University

Follow this and additional works at: https://jdc.jefferson.edu/tmf
Part of the Medicine and Health Sciences Commons

Let us know how access to this document benefits you
Recommended Citation
Marrero, MD, Dana and Wright, MD, Kelly (2012) "A 47-Year-Old Female with Shortness of Breath," The Medicine Forum: Vol. 13 ,
Article 5.
DOI: https://doi.org/10.29046/TMF.013.1.006
Available at: https://jdc.jefferson.edu/tmf/vol13/iss1/5

This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
The Medicine Forum by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.

Marrero, MD and Wright, MD: A 47-Year-Old Female with Shortness of Breath

The Medicine Forum

A 47-Year-Old Female with Shortness of Breath
Dana Marrero, MD and Kelly Wright, MD

This patient is a 47-year-old female with a history of end-stage
liver disease secondary to hepatitis C virus (HCV) complicated
by hepatic encephalopathy, obstructive sleep apnea, asthma,
and severe peripheral neuropathy who presents to the hospital
with complaints of shortness of breath and cough. The patient
was recently discharged from an outside hospital 2 days prior
to this admission where she was treated for pneumonia and an
asthma exacerbation but her symptoms have not improved. She
complains of shortness of breath at rest and severely decreased
exercise tolerance with dyspnea while walking across the room.
Her cough is persistent and non-productive. Review of systems
is also positive for fevers at the outside hospital and worsening
peripheral neuropathy which has not responded to treatment with
gabapentin. Social history is positive for 20 pack-year smoking
history (quit 10 years ago), and heavy alcohol use in the past.
On presentation to the hospital the patient was dyspneic and
in moderate respiratory distress. She was afebrile and hypoxic
to 91% on 2 liters of oxygen via nasal cannula. She had coarse
breath sounds and wheezing throughout her lung fields,
significant abdominal distension, and 2 + lower extremity
pitting edema bilaterally. Initial chest x-ray revealed bilateral
patchy airspace opacities and low lung volumes. Admission labs
were within normal limits.

Hospital Course
The initial differential diagnosis included influenza, pneumonia,
congestive heart failure exacerbation, interstitial lung disease,

Figure 2. Lung tissue from transbronchial biopsy showing
interstitial pneumonitits
COPD or asthma exacerbation, and hepatopulmonary
syndrome. On admission, the patient was empirically treated for
health care acquired pneumonia with broad spectrum antibiotics
as well as steroids and nebulizer treatments for asthma/COPD
exacerbation. Echocardiogram showed normal left and right
ventricular function without significant valve abnormalities or
intrapulmonary shunting. Shortly after admission the patient’s
oxygen needs increased and she became lethargic requiring
transfer to the intensive care unit and initiation of high flow
nasal cannula to maintain her oxygen saturation. On hospital
day # 3 the patient’s respiratory PCR came back positive
for H1N1; however, a chest CT obtained on hospital day #4
revealed airspace disease worse than expected from influenza
alone (Figure 1), and she underwent bronchoscopy with
transbronchial biopsies on hospital day #5; pathology reports
revealed interstitial pneumonitis (Figure 2). Subsequent lab
work, including 9% cryocit and decreased complement levels,
supported the diagnosis of cryoglobulinemia with pulmonary
involvement. Patient underwent treatment with plasmapheresis
and high dose steroids with temporary improvement. However,
she subsequently required intubation for worsening respiratory
distress. Since the patient’s underlying HCV had been refractory
to treatment in the past, the decision was made to withdraw care
at this point.

Discussion

Figure 1. CT scan showing bilateral infiltrative disease
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Cryoglobulins are single or mixed immunoglobulins that
undergo reversible precipitation at low temperatures (<37°).5
Cryoglobulinemia is the presence of these immunoglobulins
in the serum which results in a clinical syndrome characterized
by systemic inflammation. Cryoglobulins are divided into 3
types via the Broucet classification system. Type 1 consists of
single monoclonal gammaglobulins and is most commonly
found in patients with lymphoproliferative disorders such as

9

1

The Medicine Forum, Vol. 13 [2012], Art. 5

multiple myeloma and Waldenstrom’s macroglobulinemia.
Types 2 and 3 (the mixed cryoglobulinemias) consist of
polyclonal IgG in complexes with either monoclonal IgM RF
or polyclonal IgM RF, respectively.1 Mixed cryoglobulinemia
presents as systemic leukocytic vasculitis of small and
medium sized vessels with multi-organ involvement.6 Mixed
cryoglobulinemias are often associated with underlying
infectious diseases, autoimmune and inflammatory disorders,
and malignancy. The most commonly associated disease is
HCV with almost 90% of patients with mixed cryoglobulinemia being infected. 2 Other associated diseases include
hepatitis B virus (HBV), lupus, rheumatoid arthritis, and
Sjogren’s syndrome.1
Cryoglobulinemia is diagnosed by a combination of laboratory,
pathologic, and clinical findings. Major laboratory criteria
include a cryocit (percent of precipitating cryoglobulins in the
serum) >2% and low C4. Minor criteria include the presence
of rheumatoid factor, HCV and HBV. The major pathologic
criterion is a finding of leukocytoclastic vasculitis and the
minor criterion is the presence of clonal b-cell infiltrates under
light microscopy. Clinical findings include purpura, chronic
hepatitis, and signs of systemic vasculitis.5
HCV results in cryoglobulinemic vasculitis through the
polyclonal activation of B cells resulting in the production of
autoantibodies including rheumatoid factor and cryoprecipitable immune complexes. These complexes are then deposited
on endothelial surfaces of the affected vessels leading to
systemic vasculitis.2 Low levels of circulating cryoglobulins are
found in approximately 50% of patients with HCV but only a
small number of patients actually develop symptoms. Risks for
the development of cryoglobulinemia in the setting of HCV
infection include age, cirrhosis, and the absence of immunosuppression.7
The syndrome of mixed cryoglobulinemia is characterized
clinically by purpura, weakness, and arthralgias; and by a series
of pathological conditions representing end organ damage by
the precipitating cryoglobulins. These include membranoproliferative glomerulonephritis, alveolitis, peripheral neuropathy,
skin ulcers, Raynaud’s phenomenon, and less frequently,
lymphatic and hepatic malignancies.6
Respiratory symptoms of cough, dyspnea, and pleuritic pain
are reported in 40-50% of patients with cryoglobulinemia. The
findings of pulmonary vasculitis and interstitial infiltrates,
as seen in our patient, have only been demonstrated in case
reports. Three cases of patients with chronic HCV published
in CHEST in October, 2001 are summarized here. The first is
a 45-year-old female who presented with shortness of breath
leading to respiratory failure and mechanical ventilation.
Her bronchoscopy demonstrated alveolar hemorrhage and
pathology showed diffuse interstitial infiltrates composed
of lymphocytes. She improved with plasmapheresis. The
second patient is a 42 -year-old female who presented with
progressive weakness and sensory loss of her upper and
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lower extremities consistent with peripheral neuropathy.
She subsequently developed respiratory failure requiring
mechanical ventilation. Pathology from her bronchoscopy
also demonstrated lymphocytic alveolitis with diffuse alveolar
damage. She improved with plasmapheresis. The third patient
is a 54-year-old male who presented with cough and dyspnea.
Pathology demonstrated diffuse pneumonitis with prominent
interstitial lymphocytes. He improved with supportive care. All
three patients had bilateral patchy ground glass opacities on
chest CT and an elevated cryocit as were seen in our patient.2
The mainstay of treatment for the cryoglobulinemic syndrome
in most patients is to address the underlying HCV, usually with
interferon and an antiviral such as ribavirin. Other treatments
include immunosuppression with steroids or oral cyclophosphamide, as well as plasma exchange to remove the circulating
cryoglobulins.5 Evidence shows that cryoglobulinemia should
be treated with antivirals even if no other indication for treating
HCV exists.6 One study looking at the effectiveness of treating
mixed cryoglobulinemia with interferon reported a response
rate of approximately 70% which correlates with normalization
of ALT and decreased RNA HCV titers. However, sustained
response, defined as maintaining undetectable cryoglobulin
levels at 6 months, only occurred in 14% of patients. Good
response to interferon is associated with male sex, lower viral
load, and favorable genotype. Lack of sustained response,
especially with severe end organ manifestations of cryoglobulinemia, may ultimately be secondary to a higher HCV viral
load.4 It is important to note that even if a patient is having
improvement in their laboratory values there may not be any
appreciable symptomatic improvement. One hypothesis for
this is that the virus forms complexes with the cryoglobulins.
So even when treatment seems to be leading to decreased ALT
and circulating HCV RNA there is still a large amount of virus
contained in the cryoglobulin complexes.6

Conclusion
Pulmonary involvement secondary to cryoglobulinemia is
rarely on the differential of a patient presenting with cough
and respiratory distress. However, the increasing prevalence
of HCV makes the recognition of mixed cryoglobulinemia
and its sequelae more important. A better understanding of
the pulmonary manifestations of cryoglobulinemia, such as
were seen in our patient, may lead to earlier identification and
treatment of patients with this disease.
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